JP2007522178A5 - - Google Patents

Download PDF

Info

Publication number
JP2007522178A5
JP2007522178A5 JP2006552575A JP2006552575A JP2007522178A5 JP 2007522178 A5 JP2007522178 A5 JP 2007522178A5 JP 2006552575 A JP2006552575 A JP 2006552575A JP 2006552575 A JP2006552575 A JP 2006552575A JP 2007522178 A5 JP2007522178 A5 JP 2007522178A5
Authority
JP
Japan
Prior art keywords
methyl
oxy
benzothien
acetic acid
trifluoromethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006552575A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007522178A (ja
Filing date
Publication date
Priority claimed from GBGB0403148.0A external-priority patent/GB0403148D0/en
Application filed filed Critical
Publication of JP2007522178A publication Critical patent/JP2007522178A/ja
Publication of JP2007522178A5 publication Critical patent/JP2007522178A5/ja
Pending legal-status Critical Current

Links

JP2006552575A 2004-02-12 2005-02-10 心臓血管疾患の治療に有用なベンゾフランおよびベンゾチオフェン誘導体 Pending JP2007522178A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0403148.0A GB0403148D0 (en) 2004-02-12 2004-02-12 Chemical compounds
PCT/EP2005/001540 WO2005077926A2 (en) 2004-02-12 2005-02-10 Benzofuran and benzothiophene derivatives useful for the treatment of cardiovascular disease

Publications (2)

Publication Number Publication Date
JP2007522178A JP2007522178A (ja) 2007-08-09
JP2007522178A5 true JP2007522178A5 (https=) 2007-11-15

Family

ID=32011809

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006552575A Pending JP2007522178A (ja) 2004-02-12 2005-02-10 心臓血管疾患の治療に有用なベンゾフランおよびベンゾチオフェン誘導体

Country Status (8)

Country Link
US (1) US20070155805A1 (https=)
EP (1) EP1740568B1 (https=)
JP (1) JP2007522178A (https=)
AT (1) ATE415395T1 (https=)
DE (1) DE602005011267D1 (https=)
ES (1) ES2317192T3 (https=)
GB (1) GB0403148D0 (https=)
WO (1) WO2005077926A2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1980891B (zh) * 2004-05-03 2011-03-09 詹森药业有限公司 作为选择性雄激素受体调节剂(sarms)的吲哚、苯并呋喃和苯并噻吩衍生物
TWI359810B (en) * 2004-11-04 2012-03-11 Mitsubishi Tanabe Pharma Corp Carboxylic acid derivative containing thiazole rin
WO2006101454A1 (en) * 2005-03-21 2006-09-28 S*Bio Pte Ltd Benzothiophene derivatives: preparation and pharmaceutical applications
CN101466687B (zh) 2006-04-18 2012-04-11 日本化学医药株式会社 过氧化物酶体增殖剂激活受体δ的激活剂
AU2008338963A1 (en) * 2007-12-13 2009-06-25 Sri International PPAR-delta ligands and methods of their use
EP2277874B1 (en) * 2008-04-15 2018-06-27 Nippon Chemiphar Co., Ltd. Activator for peroxisome proliferator-activated receptor
CN102724978A (zh) * 2009-08-14 2012-10-10 塞伦尼斯治疗公司 用于治疗或预防炎症或能量代谢/产生相关疾病的PPARδ配体的用途
JP5929483B2 (ja) * 2011-05-10 2016-06-08 住友化学株式会社 植物の生長を促進する方法
JP5929482B2 (ja) * 2011-05-10 2016-06-08 住友化学株式会社 植物の生長を促進する方法
CN111393405B (zh) * 2019-01-02 2022-11-25 中国科学院上海药物研究所 一类含氟取代的苯并噻吩类化合物及其药物组合物及应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5859051A (en) * 1996-02-02 1999-01-12 Merck & Co., Inc. Antidiabetic agents
WO1997028149A1 (en) * 1996-02-02 1997-08-07 Merck & Co., Inc. Method for raising hdl cholesterol levels
ATE293963T1 (de) * 1996-02-02 2005-05-15 Merck & Co Inc Verfahren zur behandlung von diabetes und verwandter krankheitszustände.
EP0948327B1 (en) * 1996-12-23 2006-03-08 Merck & Co., Inc. Antidiabetic agents
MXPA02007286A (es) * 2000-01-28 2002-11-29 Novo Nordisk As Derivados de acido propionico y su uso en el tratamiento de diabetes y obesidad.
JP2001261674A (ja) * 2000-03-22 2001-09-26 Mitsui Chemicals Inc ベンゾチオフェン誘導体およびそれを有効成分として含有する核内レセプター作動薬
GB0111523D0 (en) * 2001-05-11 2001-07-04 Glaxo Group Ltd Chemical compounds
US6875780B2 (en) * 2002-04-05 2005-04-05 Warner-Lambert Company Compounds that modulate PPAR activity and methods for their preparation
JP4475406B2 (ja) * 2002-07-30 2010-06-09 メルク・シャープ・エンド・ドーム・コーポレイション 異常脂血症および他の脂質障害の治療用のPPARα選択的化合物
DE60332860D1 (de) * 2002-10-28 2010-07-15 High Point Pharmaceuticals Llc Neue verbindungen, die sich f r die behandlung von durch ppar vermittelten krankheiten eignen

Similar Documents

Publication Publication Date Title
JP2004534035A5 (https=)
JP2004520377A5 (https=)
JP2004518702A5 (https=)
ES2240558T3 (es) Derivados de tiazol y oxazol como activadores de receptores activados por el proliferador de peroxisoma humano.
KR101179087B1 (ko) 인간 단백질 티로신 포스파타아제 억제제 및 이용 방법
JP2004529174A5 (https=)
JP2009541270A5 (https=)
JP2007502806A5 (https=)
ZA200100983B (en) Substituted oxazoles and thiazoles derivatives as hPPAR gamma and hPPAR alpha activators.
JP2007511485A5 (https=)
JP2009520769A5 (https=)
JP2005529965A5 (https=)
JP2007522178A5 (https=)
JP2005528348A5 (https=)
JP2007520471A5 (https=)
JP2004517100A5 (https=)
JP2005505616A5 (https=)
ZA200109804B (en) Thiazole and oxazole derivatives and their pharmaceutical use.
JP2013519680A5 (https=)
PE20080360A1 (es) Derivados 4-bencilftalazinona 2-sustituidos como antagonistas de histaminas h1 y h3
JP2007502264A5 (https=)
JP2024528036A5 (https=)
RU2019121871A (ru) Новые производные фенилпропионовой кислоты и их применение
JP2020502111A5 (https=)
JP2005534673A5 (https=)